Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Dec 2020 for 4D Molecular Therapeutics, Inc., €82k.
Filing timeline
BuySaleFariborz Kamal
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -57.5%Entry US$47.36 · Close at T+365 US$20.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fariborz Kamal: trading record in brief
Fariborz Kamal has a single filing on record, published on 17 December 2020: an open-market purchase of €82k in 4D Molecular Therapeutics, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Fariborz Kamal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,347 shares@ US$23.00100.0% of flowCommon StockSEC:0001567619-20-021288:0Canonical exit: 15 Mar 2021 (T+90)
1 of 1 declaration
